| Toprol-XL Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Toprol-XL 50 mg | tablet, extended release | oral | 1.0 each | OTC |
| Toprol-XL 200 mg | tablet, extended release | oral | 1.0 each | OTC |
| Toprol-XL 25 mg | tablet, extended release | oral | 1.0 each | OTC |
| Toprol-XL 100 mg | tablet, extended release | oral | 1.0 each | OTC |
Posted by kalisa 15 days ago
Oh and btw...I am a 46 year old female, originally diagnosed with MVP (mitral valve prolapse) and ectopic atrial tachycardia ...
Posted by kalisa 15 days ago
I started off taking Tenormin 50 mg 1 x a day and Lanoxin 25 mg 1 x a day about 21 years ago. I continued to have constant pa...
Posted by fredd217 23 days ago
i started taking toprol about 2 years ago. my doctor started to notice a trace of blood and a small amount of protein in my u...
ROUNDUP AstraZeneca's strengthened pipeline fails to impress as ... - Euro2day
... chief financial officer Simon Lowth predicted that revenues from MedImmune would cancel out losses incurred from generic competition to Toprol-XL in 2008.
Thu Jan 31 10:57:01 -0500 2008
Intestinal bleeding requires some care immediately - San Bernardino Sun
I was then placed on Toprol XL. After several weeks, I started to get dizzy and lightheaded. I was told to monitor my pressure, which I do. ...
Sat Feb 02 21:01:46 -0500 2008
Intestinal bleeding requires some care immediately - San Gabriel Valley Tribune
I was then placed on Toprol XL. After several weeks, I started to get dizzy and lightheaded. I was told to monitor my pressure, which I do. ...
Sat Feb 02 20:56:50 -0500 2008
metoprolol succinate - The succinate salt form of metoprolol, a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol succinate antagonizes beta 1-adrenergic receptors in the myocardium, thereby reducing the rate and force of myocardial contraction, and consequently a diminished cardiac output. This agent may also reduce the secretion of renin with subsequent reduction in levels of angiotensin II thus decreasing sympathetic activation, including vasoconstriction, aldosterone secretion.